Ms. Rizza Vanessa Alcaria, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1607 Shattuck Ave, Berkeley, CA 94709 Phone: 510-423-9430 Fax: 510-423-9436 |
Eileen Brigid Doyle, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2187 Shattuck Ave, Berkeley, CA 94704 Phone: 510-982-3727 Fax: 510-982-3737 |
Dr. Efren A Bose Jr., PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2222 Bancroft Way, Berkeley, CA 94720 Phone: 510-642-3249 Fax: 510-642-5759 |
Dr. Pamela Gumbs, PHARM. D. Pharmacist - Geriatric Medicare: Not Enrolled in Medicare Practice Location: 2929 Telegraph Ave, Berkeley, CA 94705 Phone: 510-508-4942 Fax: 510-843-0308 |
John Quoc Nguyen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1050 Gilman St, Berkeley, CA 94710 Phone: 510-528-8274 |
Shirley Wong, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1607 Shattuck Ave, Berkeley, CA 94709 Phone: 510-423-9430 |
Erin Bufalini, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2190 Shattuck Ave, Berkeley, CA 94704 Phone: 510-849-4691 |
Abigail Anne Casem Mamaril, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2801 Adeline St, Berkeley, CA 94703 Phone: 510-981-8392 |
Joanne T Wemmer, PHARM.D. Pharmacist - Oncology Medicare: Not Enrolled in Medicare Practice Location: 1103 Sutter St, Berkeley, CA 94707 Phone: 510-527-2787 |
Dr. Laura Polonsky, PHARM.D. Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 2450 Ashby Ave, Atla Bates Summit Department Of Pharmacy, Berkeley, CA 94705 Phone: 510-204-1503 |
Dr. Komalpreet Kaur, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1444 Shattuck Place, Berkeley, CA 94709 Phone: 510-542-5242 |
Sohyun Oh, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1050 Gilman St, Berkeley, CA 94710 Phone: 510-528-8274 |
Sonya Edogun Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1414 University Ave, Berkeley, CA 94702 Phone: 510-647-3873 |
Stephanie Chu, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1744 Solano Ave, Berkeley, CA 94707 Phone: 510-526-2452 |
Mr. Shiv R Pertab, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2310 Telegraph Ave, Berkeley, CA 94704 Phone: 510-848-5121 Fax: 510-848-5350 |
Mr. Daniel B. Dong, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1460 Catherine Dr, Berkeley, CA 94702 Phone: 510-816-0054 |
Dr. Michael Gee, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1607 Shattuck Ave, Berkeley, CA 94709 Phone: 510-423-9430 Fax: 510-423-9436 |
Gustavo Adolfo Silva, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1795 2nd St Ste B, Berkeley, CA 94710 Phone: 510-559-5440 |
Yan Yan Law, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2801 Adeline St, Berkeley, CA 94703 Phone: 510-981-8392 Fax: 510-981-8396 |
Grace Cho, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1607 Shattuck Ave, Berkeley, CA 94709 Phone: 510-423-9430 |
News Archive
Protein modification via enzymatic cross-linking is an attractive way for altering food structure so as to create products with increased quality and nutritional value. These modifications are expected to affect not only the structure and physico-chemical properties of proteins but also their physiological characteristics, such as digestibility in the GI-tract and allergenicity.
Temperature-related mortality has been decreasing in Spain over the past four decades, according to a new study led by the Barcelona Institute for Global Health, a research center supported by "la Caixa".
A phase II clinical trial found that rilonacept, an inhibitor of the protein interleukin-1 (IL-1), significantly reduced acute gout flares that occur when initiating uric acid-lowering therapy. Results of the trial—the first placebo-controlled study investigating IL-1 targeted therapy in prevention of gout flares—show rilonacept to be generally well tolerated with no serious infections or treatment-related serious adverse events reported.
Advanced Life Sciences Holdings, Inc.,a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced the publication of a research paper in the journal Bioorganic and Medicinal Chemistry Letters that reports data using the Company's core triterpenoid platform technology in the discovery and development of new cancer therapeutic agents.
› Verified 8 days ago